(Texas Tech University Health Sciences Center) Researchers from Texas Tech University Health Sciences Center (TTUHSC) have discovered the FDA approved drug bupropion (Wellbutrin, Zyban) blocks the function of the serotonin type 3A receptors (5-HT3ARs) and further characterized bupropion's pharmacological effects at these receptors.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2dPxS2m
No comments:
Post a Comment